English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Ross L. LevineThe COVID-19 pandemic has presented unprecedented challenges to society, to the health care system, and to academic medicine as a whole. It has been humbling to see the impact on every aspect of our society, including the biomedical research enterprise, of a highly contagious infectious disease that lacks definitive therapies or vaccines. Moreover, COVID-19 has presented new research and clinical questions that are being addressed at extraordinary speed, with a collaborative spirit, transparency, and “can do” approach that speaks to the power of the scientific community. As a cancer doctor and researcher, I have seen countless examples of my colleagues providing frontline clinical care and cancer scientists using their expertise to solve critical questions related to COVID-19. Despite the tragedy unfolding before us, there is much to be heartened about with respect to how our community has responded. However, the pandemic has also created many headwinds for the oncology community, with the potential for long-term consequences unless we redouble our efforts focused on cancer medicine and cancer research.It is hard to accurately delineate the impact of COVID-19 on cancer care and on the clinical oncology community. Cancer patients require frequent visits to their care provider for evaluation and for cancer therapy, and …

Cancer did not stay home for COVID-19